Science fiction is rapidly moving into the realm of reality, thanks to key trends picking up momentum in the field of healthcare. At the core of this change is Artificial Intelligence. Generative AI is revolutionizing clinical workflows by enhancing diagnostics and optimizing treatments. Doctors with AI tools now routinely predict diseases before their onset. Then there’s the rise of Ambient Technologies, such as Voice-tapping AI systems free clinicians from hours of administrative drudgery, allowing them to focus entirely on patient care.
IoMT devices and Software as a Medical Device (SaMD) solutions are enabling patient care beyond the hospital walls. Healthcare providers use Interoperability and Automation to weave together data from disparate systems. A robust focus on Cybersecurity as the trust wrapper to ensure that the fruits of this digital revolution are enjoyed by the population without second-guessing the safety of their personal data.
Artificial Intelligence has thrown open the doors for rapid analysis of tons of data to identify and match findings from patient tests, with past diagnostics to zero in on potential red flags.
Visualize AI identifying abnormal heart rhythms in ECGs by referencing patterns from thousands of previous patient records. Something that only a trained clinician with decades of experience could be trusted to do in the past.
AI-driven solutions like CardioEchoAI reduce the time for analyzing heart ultrasounds from 30 minutes to just 5 minutes.
No wonder, experts predict AI in the healthcare market will grow globally from $14.6 billion in 2023 to $102.7 billion by 2030.
Possibilities abound!
An astounding 40% of healthcare executives, enamored by the rich possibilities, have reported implementing AI tools at an early phase to assist with diagnosis, treatment planning, and administrative drudgery.
This adoption is only going to go up given the introduction of regulatory frameworks, such as the FDA’s SaMD Action Plan, that are fostering trust in AI-enabled clinical decision support (CDS), driving adoption in healthcare.
Generative AI is like an invisible magical wand. You do not see it but can see its transformational work all around you. Healthcare providers are adopting Gen AI for a growing number of use cases.
Shockingly, physicians in the US spend upwards of 2 hours daily beyond regular working hours just to document patient interactions. This can be a colossal amount of drudgery. (125 million hours annually across all physicians in 2019 in the US alone).
Why can’t technology help? That’s where Ambient Listening (AL) and intelligent transcribing step in to push the boundaries of what’s possible.
AL systems can passively listen to conversations between clinicians and patients. They tap into Natural Language Processing (NLP) to contextualize the conversations and structure them to align with clinical and EHR requirements. Think of AL as the physician’s omnipresent PA with the right document at the right time.
Ambient listening prioritizes data security and privacy to ensure patient trust and compliance with regulatory standards like HIPAA.
Close to 28% of US medical groups have reported utilizing the services of AL systems to take the load off physicians. That speaks a lot of how quickly this trend is moving towards maturity and large-scale universal adoption. Solutions like the Dragon Ambient eXperience (DAX) developed by Nuance Communications, a Microsoft company, demonstrates what’s possible by combining an AL system with OpenAI’s GPT-4 Gen AI platform.
Together, with AL systems as the ‘data harvester’ and Gen AI as the ‘data thresher’, the duo are poised to reduce inefficiencies and improve care personalization.
Healthcare professionals have long desired the ability to track patient vitals continually while not keeping them tethered to a hospital bed. Taking this a step further, can there be an associated intelligent system that acts independently of a physician, to deliver medicine or medical advice in response to changing body requirements?
The magical bullet for these two needs has materialized in the form of the Internet of Medical Things (IoMT) and Software as a Medical Device (SaMD) along with Digital Therapeutics.
Smart health wearables and home monitors aggregate real-time health data for IoMT devices, offering clinicians a comprehensive view to support predictive care.
SaMD is a standalone software that performs one or more medical functions without being part of a physical medical device. The glucose monitoring app on your phone is a good example of a SaMD.
The rising number of FDA approvals for SaMD and DTx solutions is sure to encourage widespread adoption. Similarly, healthcare providers have been incentivized to integrate IoMT into their patient care models through steps taken by the Center for Medicare & Medicaid Services (CMS) to expand reimbursements for Remote Patient Monitoring (RPM) and chronic care management. These actions by regulators have led to 88% of healthcare providers investing in or planning to adopt remote patient monitoring technologies.
A noteworthy example is the Boston Scientific’s LATITUDE NXT system that uses IoMT-enabled cardiac devices to monitor heart health in real-time, transmitting data to clinicians for timely decision-making.
For all the magic described so far to happen in a seamless manner, the underlying glue is advanced interoperability between devices and software. Health devices need to be able to communicate with each other, to perform effortless data transfers. FHIR (Fast Healthcare Interoperability Resources) is one such standard that is being embraced by healthcare ISVs. Improved interoperability alone has the potential to save $30 billion annually in the US by avoiding duplicate tests and reducing administrative errors
Automation through RPA (Robotic Process Automation), a technology that uses software bots to automate repetitive, rule-based tasks is being employed to minimize human-induced interventions and errors. Imagine a RPA that streamlines prior authorization processes by gathering necessary data, submitting requests to insurers, and tracking approvals. All without your office staff requiring as much as raise a finger.
Serverless cloud computing serves as the lubricant for RPA and interoperability to support cost-effective, scalable healthcare apps for emergencies and peak times.
With interoperability, mandated by the 21st Century Cures Act, and RPA taking the pole position for patient-centric approach to healthcare, these trends will become basic standards for all players in the healthcare ecosystem.
Underlying all healthcare innovations is the element of trust. Patients trust healthcare players with personal data. Governments have been proactive and regulatory standards like HIPAA and GDPR are being stringently enforced.
Securing EHRs against ransomware, safeguarding cloud-based digital health applications, and enhancing threat detection are use cases crucial for maintaining data integrity and patient confidentiality.
Companies like Johnson & Johnson have devised multi-layer cybersecurity strategies to mitigate risks and beef up patient trust quotient.
As an essential trust shield that allows innovations to take root, organizations must give prime attention to cybersecurity. This is reflected in the global healthcare cybersecurity spending which is estimated to touch USD 100 billion annually by 2033.
With healthcare poised for a giant tech leap, the use cases put forth by industry experts have solid scope to usher in an era of patient-centric, efficiency-driven transformation in the way healthcare services are accessed by the citizens. Government-based regulatory bodies are herding the industry in the direction of the greater good for the customer in particular and the ecosystem in general. Are MedTech companies paying attention? Are they making the right investments to grab the opportunities that are opening up?